Depressive subtypes and efficacy of antidepressive pharmacotherapy

No abstract is available for this paper.

• Publication year

  2005

• Venue

  World Journal of Biological Psychiatry

• Publication date

  2005-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/15622970510030036PMID 16166021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Pharmacological treatment].

  2007cited by this paper
• A Double-Blind, Randomized Study of Olanzapine and Olanzapine/Fluoxetine Combination for Major Depression With Psychotic Features

  2004cited by this paper
• Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.

  2004cited by this paper
• Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.

  2003cited by this paper
• Benefits and Risks of Pharmacotherapy for Dysthymia

  2003cited by this paper
• ECT response in delusional versus non-delusional depressed inpatients.

  2003cited by this paper
• Effectiveness of chromium in atypical depression: a placebo-controlled trial.

  2003cited by this paper
• A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

  2002cited by this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder

  2002cited by this paper
• Predictors of nonresponse to treatment in primary care patients with dysthymia.

  2002cited by this paper
• ECT Remission Rates in Psychotic Versus Nonpsychotic Depressed Patients: A Report from CORE

  2001cited by this paper
• Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.

  2001cited by this paper
• Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study

  2001cited by this paper
• Rapid Reversal of Psychotic Depression Using Mifepristone

  2001cited by this paper
• Maintenance desipramine for dysthymia: a placebo-controlled study.

  2001cited by this paper
• Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features

  2001cited by this paper
• Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study.

  2001cited by this paper
• Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

  2001cited by this paper
• Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

  2001cited by this paper
• Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines

  2000cited by this paper
• Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia

  2000cited by this paper
• Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

  2000cited by this paper
• Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.

  2000cited by this paper
• A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.

  2000cited by this paper
• Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology.

  2000cited by this paper
• Is psychotherapy an effective treatment for melancholia and other severe depressive states?

  1999cited by this paper
• Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline

  1999cited by this paper
• Effects of exercise training on older patients with major depression.

  1999cited by this paper
• Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments.

  1999cited by this paper
• A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

  1999cited by this paper
• Olanzapine response in psychotic depression.

  1999cited by this paper
• Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.

  1999cited by this paper
• Amisulpride versus Amineptine and Placebo for the Treatment of Dysthymia

  1999cited by this paper
• A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression

  1999cited by this paper
• Clinical predictors of acute response with quetiapine in psychotic mood disorders.

  1998cited by this paper
• Moclobemide and imipramine in chronic depression (dysthymia): an international double‐blind, placebo‐controlled trial

  1997cited by this paper
• Controlled efficacy study of fluoxetine in dysthymia

  1997cited by this paper
• [Pharmacological treatment of delusional depression].

  1996cited by this paper
• A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.

  1996cited by this paper
• Fluoxetine versus phenelzine in atypical depression.

  1996cited by this paper
• Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.

  1995cited by this paper
• Paroxetine as Antidepressant in Combined Antidepressant-neuroleptic Therapy in Delusional Depression: Observation of Clinical Use

  1995cited by this paper
• Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia.

  1994cited by this paper
• Induction of Mania with Selective Serotonin Re-uptake Inhibitors and Tricyclic Antidepressants

  1994cited by this paper
• Psychotherapy of dysthymia.

  1994cited by this paper
• Moclobemide and fluoxetine in atypical depression: a double-blind trial.

  1994cited by this paper
• A double-blind trial of bupropion versus desipramine for bipolar depression.

  1994cited by this paper
• A double‐blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia

  1994cited by this paper
• A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.

  1993cited by this paper
• Columbia Atypical Depression

  1993cited by this paper
• Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression.

  1993cited by this paper
• Paroxetine in the treatment of melancholia and severe depression

  1992cited by this paper
• Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression

  1991cited by this paper
• Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.

  1990cited by this paper
• Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studies.

  1990cited by this paper
• World federation of societies of biological psychiatry

  1990cited by this paper
• Treatment of atypical depression with moclobemide: a sequential double controlled study.

  1989cited by this paper
• A sequential double-blind controlled study of moclobemide and diazepam in patients with atypical depression.

  1989cited by this paper
• Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.

  1988cited by this paper
• Imipramine treatment for chronic depression.

  1988cited by this paper
• Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.

  1987cited by this paper
• Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study

  1986cited by this paper
• The pharmacological treatment of delusional depression.

  1985cited by this paper
• Classification of Depression and Response to Antidepressive Therapies

  1983cited by this paper
• Depression and Newcastle scales. Their relationship to Hamilton's scale.

  1972cited by this paper
• Lithium response in unipolar versus bipolar depression.

  1972cited by this paper
• The use of lithium in affective disorders. I. Acute endogenous depression.

  1968cited by this paper
• Diagnosis and natural history of gas cysts of the colon.

  1968cited by this paper
• The use of lithium in affective disorders. II. Prophylaxis of depression in chronic recurrent affective disorder.

  1968cited by this paper
• Imipramine (Tofranil) In Depressive States

  1961cited by this paper
• Imipramine (Tofranil) in depressive states: a controlled trial with inpatients.

  1961cited by this paper

• On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression.

  2023cites this paper
• A quantitative review on outcome-to-antidepressants in melancholic unipolar depression.

  2018cites this paper
• Systematic review of an emerging trend in china: resting-state functional connectivity in major depressive disorder.

  2015cites this paper
• Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders.

  2015cites this paper
• articleAtypical depression is more common than melancholic in fibromyalgia : an observational cohort study

  2015cites this paper
• Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (I) : Initial Choice of Antidepressant Treatment

  2013cites this paper
• Genomic Meta-Analysis Combining Microarray Studies with Confounding Clinical Variables: Application to Depression Analysis

  2012cites this paper
• Finding the pathology of major depression through effects on gene interaction networks

  2011cites this paper
• Sleep Pathologies in Depression and the Clinical Utility of Polysomnography

  2010cites this paper
• The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

  2010cites this paper
• Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study

  2010cites this paper
• Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

  2010cites this paper
• Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

  2009cites this paper
• Clinical practice recommendations for depression

  2009cites this paper
• Current trends in the assessment and somatic treatment of resistant/refractory major depression: An overview

  2008cites this paper